Iron chelation therapy in myelodysplastic syndromes and allogeneic hematopoietic cell transplantation, a delicate balance. [PDF]
Hoff FW, Schulz E, Pavletic S, Mina A.
europepmc +1 more source
From Biology to Clinical Practice: Iron Chelation Therapy With Deferasirox. [PDF]
Palumbo GA +11 more
europepmc +1 more source
Hydroxypyrone derivatives in drug discovery: from chelation therapy to rational design of metalloenzyme inhibitors. [PDF]
Arshad JZ, Hanif M.
europepmc +1 more source
Technology Access and Preferences for Smartphone App Interventions to Optimize Iron Chelation Therapy Adherence Among Adolescents, Young Adults, and Parents of Children Receiving Chronic Transfusions: Cross-Sectional Survey Study. [PDF]
Reddy P, Locke M, Badawy S.
europepmc +1 more source
Iron chelation therapy to prevent poststroke cognitive impairments: role of diabetes and sex.
Sakamuri SSVP, Sure VN, Katakam PVG.
europepmc +1 more source
Evaluation of Optical Coherence Tomography Findings and Choroidal Thickness in Beta-Thalassemia Major Patients Using Chelation Therapy. [PDF]
Bayramoglu SE +4 more
europepmc +1 more source
Size-Controlled Mesoporous Silica Nanoparticles via Template Nanoarchitectonics from a Deferoxamine Derivative for Enhanced Blood-Brain Barrier Permeability and Neuroprotective Chelation Therapy. [PDF]
Onrubia-Márquez M +10 more
europepmc +1 more source
Prognostic Factors and Clinical Considerations for Iron Chelation Therapy in Myelodysplastic Syndrome Patients. [PDF]
Parisi S, Finelli C.
europepmc +1 more source
Role of Antioxidant Supplementation in Enhancing Chelation Therapy for Lead-Induced Oxidative Stress in Rats. [PDF]
Waidande SS +3 more
europepmc +1 more source
Iron Chelation Therapy With Deferasirox in Sickle Cell Disease With End-Stage Renal Disease. [PDF]
Raj A +4 more
europepmc +1 more source

